Someone above you has decided the company needs this. You have been asked to find out which one, and to come back with a recommendation by a date that was picked before anyone asked how long it would take.
That is how most enterprise AI evaluations start, and the shape of it matters more than anything you will do in the next twelve weeks. You are not being asked whether to buy. You are being asked which to buy, which is a different question wearing the same clothes.
I have run this badly. Not spectacularly, just ordinarily. We picked well, on the whole, and I still gave away most of my position in the first two meetings without noticing. What follows is the part I would explain to myself at the start.
The asymmetry nobody mentions
Consider a composite that merges several evaluations I’ve been close to: a mid-size insurer, a document-heavy claims process, a mandate to reduce handling time. Illustratively, the buying team was one program manager at roughly sixty percent of her time, a claims lead who joined for the demos, and a security architect who appeared twice. Three people, none of them full time.
On the other side, five: an account executive, a solution engineer, a customer success lead assigned before the contract existed, a pricing specialist who never appeared on a call but shaped every number, and a former claims executive whose entire function was to sound like the buyer.
That ratio is normal. It is not a sign of anything sinister. It reflects a difference in how often each side does this.
The vendor team had run some version of this process a few hundred times. The buying team had run it twice, four years apart, for different software in a different category. Everything the buyer treated as a decision, the seller had already seen resolved a hundred ways and knew which way it usually went.
Three asymmetries follow from that, and they compound.
Repetition. They know your process better than you do. They know that security review takes six weeks at a firm your size, that your quarter-end matters less than theirs, that the claims lead will go quiet in August. They have a name for the stage you are in.
Information. They know what their other customers pay, what discount their manager will approve without escalating, which of your requirements they cannot meet and are planning to answer around. You know almost none of the equivalent.
Time. Their timeline is a quarter. Yours is however long the sponsor’s attention lasts, which is usually shorter. Whoever can wait longer wins, and it will rarely be you.
What you actually hold
There are exactly two things you know that they cannot, and both are worth more than they look.
The first is what your organization will genuinely do with the thing once it arrives. Not the use case in the business case. The real one. Whether the claims handlers will use it, whether the team lead will quietly tell them not to, whether the data it needs is in the state you told everyone it was in. The vendor is guessing at this, and their guess is optimistic because their guess has to be.
The second is what your internal politics will tolerate. Which sponsor can carry an eight-figure request. Which function has veto power in practice regardless of what the governance document says. Whether a failed pilot ends the project or gets absorbed and repeated.
Most buyers give both away in the first two meetings. Not deliberately. It comes out in the discovery call, which is a well-designed instrument for extracting exactly these two things while feeling like a conversation about your needs. You will be asked about your timeline, your budget cycle, your approval chain, and who else you’re looking at. Each answer is a real question about how much room you have, dressed as project logistics.
You do not have to be cagey about it, and being cagey has its own costs. You do have to know which questions those are while you are answering them.
The four sentences
Before the first vendor call, write four things down. Not in a document anyone circulates. On one page, for you.
The decision. What is actually being decided, in one sentence, and by whom. If the honest version is “whether we appear to be doing something about AI this year,” write that. You cannot run a good evaluation against a stated goal you don’t believe.
The no. What would make you recommend against all of them. This is the important one and it is almost never written down. An evaluation with no defined failure condition cannot produce a no, and everyone in the process knows it within about three weeks.
The date and who owns it. Not the date on the plan. The date after which your sponsor stops caring, which is a different date and is the one that governs.
The number you will not say. Your budget ceiling, and the fact that you are not going to state it when asked in week two.
Keep that page private. Its value is that it exists before the process starts shaping your view of what a reasonable answer looks like, which it will, and faster than you expect.
The thing that changes the room
Here’s what the four sentences buy you. Roughly nine weeks in, someone will bring you a proposal with a discount attached to a date. It will be a real discount, illustratively somewhere between fifteen and thirty percent, and the date will be genuine because their quarter is genuine. Nothing about this is a trick.
At that moment you are either a person comparing an offer against a written no, or a person deciding under time pressure whether a number feels good. Those two people reach different decisions from identical information. The first one occasionally walks away. The second one has never walked away in their life and both sides know it.
The vendor’s job is to be helpful and to close. Those are not in conflict most of the time. When they do come into conflict, the process is built to resolve it their way, and no amount of goodwill on either side changes the fact that only one party does this for a living.
One thing to do differently
Write the no before the first call. One paragraph, dated, saved somewhere you will find it in November: the conditions under which the honest recommendation is that we do not buy any of these this year.
You will probably still buy. Most evaluations that should end in a purchase do. But you’ll be negotiating from a position where not buying is a live option you have already described in writing, and that is a materially different chair to sit in than the one you get by default.